lstituto Europeo di Oncologia

Milan 20141

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, HER2-positive Breast Cancer

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid Tumors — Completed